Academic literature on the topic 'Drug absorption/disposition'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Drug absorption/disposition.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Drug absorption/disposition"

1

Beringer, Paul M., and Richard L. Slaughter. "Transporters and Their Impact on Drug Disposition." Annals of Pharmacotherapy 39, no. 6 (2005): 1097–108. http://dx.doi.org/10.1345/aph.1e614.

Full text
Abstract:
OBJECTIVE: To review the recent advances in knowledge about human transporters and their effect on drug disposition. DATA SOURCES: A MEDLINE search (1996–March 2005) was performed to identify pertinent literature on human transporters and their impact on drug disposition. Additional articles were identified from a manual search of the references of retrieved articles. STUDY SELECTION AND DATA EXTRACTION: Based on the identified studies, data were extracted on the impact of transporters on drug absorption, distribution, and elimination. DATA SYNTHESIS: The pharmacokinetic disposition of drugs i
APA, Harvard, Vancouver, ISO, and other styles
2

Young, Sharon L. "Drug Disposition in the Pediatric Patient." Journal of Pharmacy Practice 2, no. 1 (1989): 13–20. http://dx.doi.org/10.1177/089719008900200103.

Full text
Abstract:
The pediatric patient is a unique individual who undergoes continual physiologic change from the time of conception through adolescence. The pharmacokinetics of therapeutic agents are influenced by physiologic changes that ultimately affect drug therapy. The gastric absorption of many therapeutic agents is altered by changes in gastric pH, gastric emptying, intestinal motility, biliary function, pancreatic function, and regional blood flow. Intramuscular absorption is erratic and unpredictable because of reduced skeletal muscle mass, alterations in regional blood flow, and physical activity. P
APA, Harvard, Vancouver, ISO, and other styles
3

Dokoumetzidis, Aristides, and Panos Macheras. "Fractional kinetics in drug absorption and disposition processes." Journal of Pharmacokinetics and Pharmacodynamics 36, no. 2 (2009): 165–78. http://dx.doi.org/10.1007/s10928-009-9116-x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Lemmens, Glenn, Arno Van Camp, Stephanie Kourula, Tim Vanuytsel, and Patrick Augustijns. "Drug Disposition in the Lower Gastrointestinal Tract: Targeting and Monitoring." Pharmaceutics 13, no. 2 (2021): 161. http://dx.doi.org/10.3390/pharmaceutics13020161.

Full text
Abstract:
The increasing prevalence of colonic diseases calls for a better understanding of the various colonic drug absorption barriers of colon-targeted formulations, and for reliable in vitro tools that accurately predict local drug disposition. In vivo relevant incubation conditions have been shown to better capture the composition of the limited colonic fluid and have resulted in relevant degradation and dissolution kinetics of drugs and formulations. Furthermore, drug hurdles such as efflux transporters and metabolising enzymes, and the presence of mucus and microbiome are slowly integrated into d
APA, Harvard, Vancouver, ISO, and other styles
5

Gao, Song, Edward C. Bell, Yun Zhang, and Dong Liang. "Racial Disparity in Drug Disposition in the Digestive Tract." International Journal of Molecular Sciences 22, no. 3 (2021): 1038. http://dx.doi.org/10.3390/ijms22031038.

Full text
Abstract:
The major determinants of drug or, al bioavailability are absorption and metabolism in the digestive tract. Genetic variations can cause significant differences in transporter and enzyme protein expression and function. The racial distribution of selected efflux transporter (i.e., Pgp, BCRP, MRP2) and metabolism enzyme (i.e., UGT1A1, UGT1A8) single nucleotide polymorphisms (SNPs) that are highly expressed in the digestive tract are reviewed in this paper with emphasis on the allele frequency and the impact on drug absorption, metabolism, and in vivo drug exposure. Additionally, preclinical and
APA, Harvard, Vancouver, ISO, and other styles
6

Custodio, Joseph M., Chi-Yuan Wu, and Leslie Z. Benet. "Predicting drug disposition, absorption/elimination/transporter interplay and the role of food on drug absorption." Advanced Drug Delivery Reviews 60, no. 6 (2008): 717–33. http://dx.doi.org/10.1016/j.addr.2007.08.043.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

TAMAI, IKUMI. "Membrane Transporters as Determinant of Drug Absorption and Disposition." Drug Metabolism and Pharmacokinetics 11, no. 6 (1996): 642–50. http://dx.doi.org/10.2133/dmpk.11.642.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Brocks, Dion R., and Neal M. Davies. "Lymphatic Drug Absorption via the Enterocytes: Pharmacokinetic Simulation, Modeling, and Considerations for Optimal Drug Development." Journal of Pharmacy & Pharmaceutical Sciences 21, no. 1s (2018): 254s—270s. http://dx.doi.org/10.18433/jpps30217.

Full text
Abstract:
Most orally administered drugs gain access to the systemic circulation by direct passage from the enterocyte layer of the intestinal tract to the mesenteric blood capillaries. Intestinal lymphatic absorption is another pathway that certain drugs may follow to gain access to the systemic circulation after oral administration. Once absorbed, drug diffuses into the intestinal enterocyte and while in transit may associate with fats as they are processed into chylomicrons within the cells. The chylomicron-associated drug is then secreted from the enterocyte into the lymphatic circulation, thus avoi
APA, Harvard, Vancouver, ISO, and other styles
9

Shi, Shaojun, and Yunqiao Li. "Interplay of Drug-Metabolizing Enzymes and Transporters in Drug Absorption and Disposition." Current Drug Metabolism 15, no. 10 (2015): 915–41. http://dx.doi.org/10.2174/1389200216666150401110610.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Reed, Michael D. "The Ontogeny of Drug Disposition: Focus on Drug Absorption, Distribution, and Excretion." Drug Information Journal 30, no. 4 (1996): 1129–34. http://dx.doi.org/10.1177/009286159603000431.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Dissertations / Theses on the topic "Drug absorption/disposition"

1

McGee, John Paul. "Studies on the absorption and disposition of trilostane." Thesis, University of Nottingham, 1989. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.238258.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Sit, T. F. L. "Investigation by compartmental and statistical analyses of the disposition of topically applied drugs." Thesis, Open University, 1989. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.234760.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Matsson, Pär. "ATP-Binding Cassette Efflux Transporters and Passive Membrane Permeability in Drug Absorption and Disposition." Doctoral thesis, Uppsala University, Department of Pharmacy, 2007. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-8371.

Full text
Abstract:
<p>Transport into and across the cells of the human body is a prerequisite for the pharmacological action of drugs. Passive membrane permeability and active transport mechanisms are major determinants of the intestinal absorption of drugs, as well as of the distribution to target tissues and the subsequent metabolism and excretion from the body. In this thesis, the role of ATP-binding cassette (ABC) transporters and passive permeability on drug absorption and disposition was investigated. Particular emphasis was placed on defining the molecular properties important for these transport mechanis
APA, Harvard, Vancouver, ISO, and other styles
4

Petri, Niclas. "Involvement of Membrane Transport Proteins in Intestinal Absorption and Hepatic Disposition of Drugs Using Fexofenadine as a Model Drug." Doctoral thesis, Uppsala University, Department of Pharmacy, 2005. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-5808.

Full text
Abstract:
<p>The aims of this thesis were to study the in vivo relevance of membrane transporters for intestinal absorption and the hepatic disposition of drugs in humans and preclinical models. Fexofenadine is a substrate for ABCB1 (P-glycoprotein) and members of the organic anion transporting polypeptide (OATP/SLCO) family. It is marginally metabolised in humans. </p><p>The influence of known inhibitors of ABCB1 and OATPs on the membrane transport and pharmacokinetics of fexofenadine was investigated in Caco-2 and porcine models and in humans. The permeability of fexofenadine remained low, even when s
APA, Harvard, Vancouver, ISO, and other styles
5

Klausen, Maxime. "Nouvelles sondes moléculaires photo-activées pour la délivrance de principes actifs : de la conception aux applications biologiques." Thesis, Bordeaux, 2018. http://www.theses.fr/2018BORD0077.

Full text
Abstract:
La photolibération d'agents biologiques cagés par des groupements protecteurs photolabiles (PPGs) a récemment attiré un intérêt croissant en thérapie et physiologie. La combinaison de cet outil avec les avantages de l'absorption à deux photons (2PA) dans le proche IR est cependant un défi. Dans ces travaux, nous présentons deux voies différentes vers de nouveaux décageurs efficaces en 2PA.Nous élaborons d’abord une série de systèmes tandem basés sur le FRET, combinant des antennes quadrupolaires 2PA avec des modules PPGs appropriés. La modification des blocs constitutifs de ces composés nous a
APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "Drug absorption/disposition"

1

Waterbeemd, H. "Relation of Molecular Properties with Drug Absorption and Disposition." In Pharmacokinetic Challenges in Drug Discovery. Springer Berlin Heidelberg, 2002. http://dx.doi.org/10.1007/978-3-662-04383-7_11.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Sakagami, Masahiro, and Mark Gumbleton. "Targeted Drug Delivery Through the Respiratory System: Molecular Control on Lung Absorption and Disposition." In Controlled Pulmonary Drug Delivery. Springer New York, 2011. http://dx.doi.org/10.1007/978-1-4419-9745-6_6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Lindley, David J., Stephen M. Carl, Dea Herrera-Ruiz, et al. "Drug Transporters and Their Role in Absorption and Disposition of Peptides and Peptide-Based Pharmaceuticals." In Oral Bioavailability. John Wiley & Sons, Inc., 2011. http://dx.doi.org/10.1002/9781118067598.ch18.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Aronson, J. K. "General principles of drug therapy in psychiatry." In New Oxford Textbook of Psychiatry. Oxford University Press, 2012. http://dx.doi.org/10.1093/med/9780199696758.003.0151.

Full text
Abstract:
The successful use of psychotropic drugs demands an understanding of their pharmaceutical, pharmacokinetic, and pharmacodynamic properties. ♦ Pharmaceutical properties: Pharmaceutical formulations can be manipulated to produce different durations of action, for example the use of oily emulsions of antipsychotic drugs in depot formulations. ♦ Pharmacokinetic properties: Pharmacokinetics is the mathe-matical description of the disposition of drugs in the body by absorption, distribution (to plasma proteins and tissues), and elimination (usually by hepatic metabolism and renal excretion). Differences in drug disposition determine differences in dosage regimens and are important for drug interactions. ♦ Pharmacodynamic properties: Pharmacodynamics is the study of the pharmacological actions of drugs and how actions at the molecular level are translated, via actions at cellular, tissue, and organ levels, into therapeutic or adverse effects. The known pharmacological actions of psychotropic drugs are not necessarily the actions that produce their therapeutic or adverse effects.
APA, Harvard, Vancouver, ISO, and other styles
5

Estes, Lynn L. "Pharmacokinetics and Pharmacodynamics of Antimicrobials." In Mayo Clinic Infectious Diseases Board Review. Oxford University Press, 2012. http://dx.doi.org/10.1093/med/9780199827626.003.0001.

Full text
Abstract:
Pharmacokinetics is the disposition of drugs in the body (how the body acts on the drug); it incorporates terms such as absorption, bioavailability, distribution, protein binding, metabolism, and elimination. Pharmacodynamics is the interaction between the drug concentration at the site of action over time (drug exposure) and the pharmacologic effect, which, in the case of antimicrobials, is eradication of microorganisms. Pharmacokinetics and pharmacodynamics are interrelated. Both need to be taken into account to optimize antimicrobial therapy.
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!